ORAMED PHARMACEUTICALS INC. (ORMP) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $1.99M | — |
| 2019 | $90.0K | +204.7% |
| 2018 | -$86.0K | -146.0% |
| 2017 | $187.0K | -61.8% |
| 2016 | $490.0K | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $1.99M | — |
| 2019 | $90.0K | +204.7% |
| 2018 | -$86.0K | -146.0% |
| 2017 | $187.0K | -61.8% |
| 2016 | $490.0K | — |